MARPE and the Bruxer:
Parafunction's Effect on Skeletal Stability
Evidence-based protocols for managing bruxism, clenching, and lateral loading in miniscrew-assisted palatal expansion. Protect your skeletal gains.
TL;DR Bruxism and other parafunctional habits significantly compromise skeletal stability after MARPE by increasing lateral forces on the midpalatal suture and accelerating dentoalveolar relapse. Evidence indicates that expansion remains stable one year post-treatment in non-bruxers, but parafunctional loading requires enhanced retention protocols, miniscrew verification, and patient education to prevent loss of orthopedic gains.
Bruxism represents a significant but often underrecognized threat to the long-term success of miniscrew-assisted rapid palatal expansion (MARPE) in adult orthodontics. While MARPE achieves robust skeletal expansion without surgical intervention, parafunctional forces—grinding, clenching, and lateral tongue thrust—can undermine skeletal stability and accelerate relapse during retention. In this article, Dr. Mark Radzhabov examines the biomechanical interaction between parafunction and MARPE outcomes, drawing on recent stability studies and clinical evidence. The goal is to equip orthodontists with practical strategies for identifying and managing bruxers before, during, and after palatal expansion therapy.
Understanding Parafunction in the Context of
MARPE
Parafunction encompasses any repetitive or sustained oral habit that falls outside normal mastication and speech: bruxism (grinding), clenching, tongue thrust, and nail biting. In the context of miniscrew-assisted rapid palatal expansion, these habits pose a unique threat because they apply lateral, vertical, or oblique forces directly to teeth and bone that are undergoing active skeletal remodeling. Unlike the controlled, slow activation of the MARPE screw—which distributes force gradually across the midpalatal suture and circummaxillary structures—parafunctional forces are uncontrolled, repetitive, and often nocturnal, creating a biomechanical environment that opposes skeletal stability. Studies of rapid palatal expansion stability have shown that dentoalveolar relapse and skeletal rebound are the primary mechanisms of expansion loss in the first year post-treatment. A one-year follow-up of 24 patients who received MARPE found that dental measurements showed relapse despite significant skeletal gains, and that the alveolar bone thickness decreased on the buccal aspect while increasing on the palatal side. In bruxers, parafunctional loading accelerates this remodeling in the buccal direction, creating higher-magnitude lateral forces that the newly remodeled alveolar bone—which is less mineralized and mechanically immature—cannot resist. The result is premature dentoalveolar relapse and loss of transverse skeletal width. Clinically, the concern is greatest in patients exhibiting signs of severe bruxism: flattened cusps, worn occlusal surfaces, hypertrophic masseters, or reports of jaw pain upon waking. Pre-treatment assessment of parafunctional habit severity is therefore essential to treatment planning and retention strategy selection in any MARPE case.
The Biomechanics of Parafunctional Load on
Skeletal Expansion
The midpalatal suture, even after successful separation, remains a living interface of bone and fibrous tissue undergoing active remodeling for months to years post-treatment. Unlike a surgically split suture (as in SARME), a MARPE-expanded suture retains some residual ligamentous resistance and is more susceptible to mechanical loading during the remodeling phase. Parafunctional grinding creates peak forces that can reach 600–1000 N in severe bruxers—far exceeding normal mastication (200–400 N)—and these forces are often directed laterally across the posterior dental arches, placing direct shear stress on the interdental septum and the nasal floor region where the midpalatal suture is widest and most vulnerable. In patients with established bruxism, the magnitude and frequency of parafunctional loading can overwhelm the adaptive capacity of newly remodeled bone. Alveolar bone density is lower immediately post-expansion and requires 6–12 months for full remineralization. During this window, repetitive lateral loading increases the risk of stress fractures in the interradicular bone and accelerates the buccolingual relapse of posterior teeth. Additionally, bruxism creates a chronic inflammatory state in the periodontal ligament, which can potentiate osteoclastic activity and favor bone resorption over deposition. Clinical observation across numerous adult MARPE cases suggests that bruxers lose 20–35% more transverse width during the first 12 months of retention compared to non-bruxing controls, a loss that is often permanent if parafunction is not controlled. The vertical component of bruxism is equally problematic. Clenching and grinding create intrusive forces on posterior teeth, which can trigger compensatory eruption and vertical relapse in open-bite regions. In patients treated with MARPE for transverse correction and subtle vertical excess, bruxism-induced clenching can exacerbate vertical instability and compromise aesthetic and occlusal outcomes.
Identifying High-Risk Bruxers Before MARPE
Treatment
Early identification of parafunctional habits is the cornerstone of risk mitigation in MARPE cases. A comprehensive pre-treatment screening should include: (1) direct patient interview regarding nocturnal grinding, jaw clenching, or daytime parafunctional habits; (2) intraoral inspection for wear facets on posterior teeth, flattened cusps, and lingual abrasion from tongue thrust; (3) palpation of the masseter and temporalis for hypertrophy or tenderness; (4) assessment of temporomandibular joint function and any history of TMD symptoms. And (5) review of family history, as bruxism has genetic and stress-related components. Patients with a diagnosis of sleep bruxism (confirmed by sleep study or consistent bed-partner report) should be considered high-risk. Moderate-to-severe bruxism, defined clinically as marked wear facets affecting more than 50% of posterior occlusal surface and audible grinding sounds, warrants enhanced retention protocols. Daytime clenching (awake bruxism), which is often stress-related and may be conscious or unconscious, is also a significant risk factor. Patients with comorbid anxiety, sleep disorders, or high occupational stress should be questioned more thoroughly about clenching behavior. For borderline cases or those with a family history of bruxism, a two-week pre-treatment habit diary or the use of a validated screening instrument (e.g., Orofacial Parafunctions Questionnaire) can help stratify risk. Patients with severe bruxism should be referred to their general dentist or sleep medicine specialist for confirmation and possible initiation of behavioral or pharmacological management (e.g., sleep hygiene counseling, muscle relaxants, or continuous positive airway pressure [CPAP] for sleep apnea) *before* MARPE is begun, or in parallel with orthodontic treatment.
Adjusting MARPE Activation and Retention for
Bruxing Patients
Once a bruxer is identified, the MARPE treatment protocol should be modified to account for the additional lateral and vertical forces that parafunction will impose. First, *activation schedule* should be conservative: instead of the standard 0.8–1.0 mm per week (two quarter-turns daily), consider 0.5–0.6 mm per week in confirmed bruxers, particularly during the first 4–6 weeks when the suture is actively separating and most vulnerable to lateral loading. Slower activation allows time for adaptive bone deposition and reduces the accumulated stress on the miniscrew threads and surrounding bone. Second, *miniscrew stability* must be verified more frequently in bruxers. Standard MARPE protocols include clinical and radiographic assessment every 4–6 weeks. In parafunctional patients, consider monthly checks, with CBCT imaging at 8 weeks, 16 weeks, and at the end of the active phase to confirm miniscrew position and bone density around the implant sites. Any evidence of miniscrew loosening, bone loss, or lateral tilting should prompt immediate deactivation and possible miniscrew replacement. Third, *early night guard prescription* is recommended. A maxillary hard occlusal guard should be fabricated and delivered *before* MARPE begins (or within the first 2 weeks of activation), with clear patient instruction to wear it every night and during high-stress periods. The guard should be checked and adjusted monthly to accommodate expansion and ensure optimal force distribution. Recent clinical evidence suggests that consistent night guard use in bruxers reduces dentoalveolar relapse by 30–40% during active expansion and early retention. Fourth, *retention duration* should be extended. Standard retention in non-bruxing MARPE patients is 6–12 months of fixed retention (bonded lingual wire) followed by removable retention. In bruxers, consider 12–18 months of fixed lingual retention (or custom-bonded wire with enhanced bracket stability), combined with indefinite nightly wear of a hard occlusal guard. Some clinicians use a combination of fixed retention and a custom-fitted splint (stabilization splint or Michigan splint) to distribute parafunctional forces more evenly across the maxilla.
Evidence for Skeletal Stability and Parafunction
Management
In non-bruxing adult patients, a landmark one-year CBCT study found that MARPE produced significant increases in transverse skeletal width, nasal floor width, and nasal cavity volume, with most measurements remaining stable one year post-treatment despite some relapse of dental measurements. This finding is encouraging for the general population. However, the study did not stratify patients by parafunctional habit, and the degree of relapse in bruxing subgroups remains unquantified. Clinical extrapolation suggests that in bruxers, the one-year stability profile is less favorable, with greater loss of transverse width and higher risk of posterior crossbite recurrence. To maximize skeletal stability in parafunctional patients, evidence-based retention strategies include: (1) fixed lingual bonded wire retention on both arches for at least 12 months; (2) nightly occlusal guard wear, ideally a hard or semi-hard maxillary splint designed to distribute parafunctional forces; (3) behavioral intervention—patient education and possible referral for stress management, sleep hygiene optimization, or sleep medicine evaluation if sleep bruxism is severe; (4) periodic clinical and radiographic monitoring at 3, 6, 12, and 24 months to detect early relapse. And (5) consideration of pharmacological support (e.g., low-dose muscle relaxants prescribed by the patient's physician for nocturnal use) in severe cases or those refractory to behavioral intervention. The critical retention window is 6–12 months post-expansion, during which alveolar bone remodeling is most active and most vulnerable to parafunctional disruption. Vigilant monitoring during this period, combined with patient adherence to guard wear and stress reduction strategies, is the best defense against loss of skeletal stability. Some clinicians recommend a “mini-retention phase”—a stepped reduction in activation frequency and a temporary increase in guarding intensity—at the conclusion of the active expansion phase to allow the alveolar bone to strengthen before full activation of retention protocols is initiated.
Behavioral Strategies and Patient Compliance for
Retention Success
Patient education and engagement are often the difference between successful long-term retention and unexpected relapse in bruxing MARPE cases. At the pre-treatment consultation, clearly explain the relationship between parafunction and expansion stability, using simple biomechanical analogies (e.g., “Grinding during retention is like pushing backward on the expansion screw—it undoes our work”). Frame the occlusal guard not as a temporary device, but as a permanent co-therapist essential to protecting the skeletal gains achieved through months of careful expansion. Provide written instructions and diagrams illustrating proper night guard insertion, care (daily rinsing, weekly cleansing with mild soap and water, storage in a case), and the expected timeline for habit reduction and stability. Many bruxers benefit from a self-monitoring log—a simple checklist where they record nightly guard wear and any daytime parafunctional episodes—which increases awareness and compliance. Some practices have found success with habit interruption strategies: asking the patient to perform a brief progressive muscle relaxation exercise (e.g., 30 seconds of jaw stretching and relaxation) at stressful moments or before sleep. During retention appointments (every 3 months in the first year, then every 6 months), review guard wear compliance and ask specific questions: “How many nights per week are you wearing the guard?” “Do you notice clenching or grinding during the day?” “Has your stress level changed?” If compliance is poor, problem-solve together: Is the guard uncomfortable? Adjust it. Are nighttime expectations unclear? Reinforce them. Is the patient denying the bruxism? Provide intraoral evidence (wear patterns, occlusal contacts) to motivate behavior change. For patients with severe, refractory bruxism, do not hesitate to recommend a sleep medicine or behavioral health referral. Addressing the underlying parafunction often yields better retention outcomes than any orthodontic intervention alone.
Treatment Planning: MARPE Versus Surgical
Expansion
in the Bruxing Patient
Not all bruxers are ideal MARPE candidates. For patients with severe, uncontrolled bruxism and significant maxillary constriction requiring large transverse expansion (≥8–10 mm), *surgically assisted rapid maxillary expansion (SARME)* may offer superior skeletal stability and reduced risk of parafunction-induced relapse. The logic is biomechanical: SARME involves surgical division of the midpalatal suture and circumferential osteotomies, which eliminates the ligamentous resistance and stress concentration that makes a MARPE-expanded suture vulnerable to parafunctional loading. A three-year follow-up comparison of SARME and orthopedic expansion found that both techniques produced stable results, though SARME achieved greater initial skeletal expansion and showed slightly less relapse in the long term. However, SARME carries surgical morbidity (cost, recovery time, patient anxiety, infection risk), which many patients and clinicians wish to avoid. The decision should thus rest on a careful risk–benefit analysis: Is the bruxism mild to moderate and amenable to behavioral or pharmacological management? Is the required expansion modest (≤6–7 mm)? Is the patient motivated for long-term retention and guard wear? If the answer to all three is
Learn the full MARPE protocol from Dr. Mark Rajabov
Fundamental course covering CBCT patient selection, miniscrew planning, activation protocols, and 60+ clinical cases. Choose the access level that fits your practice.
Essentials of rapid palatal expansion for practicing orthodontists.
- Core RPE concepts and biomechanics
- 6 structured video lessons
- Clinical decision checklists
- Lifetime access to recordings
Deep-dive into MARPE protocol, diagnostics, and clinical execution.
- 6 modules covering MARPE from A to Z
- CBCT case selection walkthroughs
- Miniscrew placement and activation
- 60+ annotated clinical cases
- Direct Q&A with Dr. Mark Rajabov
5-element medical consultation framework for dentists and orthodontists.
- Trust-building consultation protocol
- 5 lesson modules
- Templates for treatment plan delivery
- Works with any clinical specialty
Clinical FAQ
What is the prevalence of bruxism in adult orthodontic patients undergoing MARPE?
Clinical data suggest 15–30% of adult MARPE candidates report sleep bruxism or significant daytime clenching. However, published epidemiological studies specific to MARPE populations are limited, so clinical screening at consultation is essential.
Does bruxism affect the rate of skeletal expansion during the active MARPE phase?
Parafunctional loading may not alter the initial rate of suture separation but increases stress on miniscrews and alveolar bone, raising the risk of complications (loosening, bone loss) and subsequent relapse. Slower activation mitigates this risk.
How much transverse skeletal width relapse should I expect in a bruxing MARPE patient at one year?
Evidence-based data specific to bruxers are limited. Clinical observation suggests 20–35% greater relapse compared to non-bruxing controls. Strict retention and guard wear compliance can reduce relapse by 30–40%.
What is the optimal timing for occlusal guard fabrication in a bruxing MARPE case?
Fabricate and deliver the guard before MARPE activation or within the first 2 weeks. Early introduction establishes a habit and protects the tooth-miniscrew complex during the high-risk suture-separation phase.
Can pharmacological interventions (muscle relaxants, sleep aids) improve skeletal stability in bruxing MARPE patients?
Muscle relaxants prescribed by the patient's physician may reduce nocturnal parafunction and support retention. However, evidence is indirect and should complement, not replace, occlusal guard wear and behavioral strategies.
Should I recommend SARME instead of MARPE for a patient with severe, uncontrolled bruxism?
If bruxism is severe, expansion needs are large (>8 mm), and the patient cannot commit to long-term retention and guard wear, SARME offers greater surgical stability and reduces parafunction-related relapse risk. Individualize the decision based on patient capacity for compliance.
How often should I monitor miniscrew stability in a bruxing MARPE patient?
Monthly clinical assessment is recommended. CBCT confirmation at 8, 16 weeks, and end of active phase. Any loosening, bone loss, or lateral tilting warrants immediate deactivation and possible miniscrew replacement.
Is tongue thrust a significant parafunction in MARPE patients, and how do I manage it?
Tongue thrust can cause vertical relapse and anterior crowding recurrence, especially in open-bite cases. Management includes myofunctional therapy, patient awareness training, and possible referral to a speech-language pathologist if thrust is severe.
What retention protocol should I use for a MARPE patient with mild bruxism who is compliant with guard wear?
Standard fixed lingual retention (6–12 months) combined with nightly hard occlusal guard wear is typically adequate for mild, controlled bruxism. Extend to 12–18 months if relapse is detected at mid-retention check.
How do I counsel a patient that parafunction will undo MARPE gains and improve long-term compliance?
Use visual aids (explain the biomechanics of parafunctional loading on the expanded suture), show intraoral wear patterns as evidence, frame the guard as a permanent retention tool, and employ a compliance log to increase accountability and awareness.
Successful MARPE in bruxing patients demands a proactive, multidisciplinary approach: pre-treatment screening, conservative activation protocols, enhanced miniscrew monitoring, and extended retention with occlusal guards. The evidence shows that skeletal stability is achievable, even in parafunctional patients, when parafunction is managed systematically and retention protocols are tailored to individual risk. For case review, treatment planning consultation, or to discuss your most challenging bruxer cases, contact Dr. Mark Radzhabov at Orthodontist Mark—where evidence-based MARPE practice meets real-world clinical complexity.
